Wells Fargo Maintains Overweight on Tectonic Therapeutic, Lowers Price Target to $93

Tectonic Therapeutic Inc

Tectonic Therapeutic Inc

TECX

0.00

Wells Fargo analyst Tiago Fauth maintains Tectonic Therapeutic (NASDAQ: TECX) with a Overweight and lowers the price target from $101 to $93.